Accounting for variability in individual hierarchical clinical trial data.
- Published in:
- Pharmaceutical Statistics, 2008, v. 7, n. 4, p. 285, doi. 10.1002/pst.313
- By:
- Publication type:
- Article
Works matching IS 15391604 AND DT 2008 AND VI 7 AND IP 4
Results: 13
1
2
Literature Review July-September 2008.
- Published in:
- Pharmaceutical Statistics, 2008, v. 7, n. 4, p. 302, doi. 10.1002/pst.353
- By:
- Publication type:
- Article
3
Adaptive design methods in clinical trials Shein-Chung Chow, Mark Chang (2006) ISBN: 9781584887768; 296 pages; £49.99, $89.95 Chapman & Hall/CRC;.
- Published in:
- Pharmaceutical Statistics, 2008, v. 7, n. 4, p. 306, doi. 10.1002/pst.324
- By:
- Publication type:
- Article
4
Sequential design approaches for bioequivalence studies with crossover designs.
- Published in:
- Pharmaceutical Statistics, 2008, v. 7, n. 4, p. 245, doi. 10.1002/pst.294
- By:
- Publication type:
- Article
5
An Introduction to Categorical Data Analysis (second edition) Alan Agresti (2007) ISBN: 9780471226185; 372 pages; £50.30, $94.9, €66.40 Wiley;.
- Published in:
- Pharmaceutical Statistics, 2008, v. 7, n. 4, p. 307, doi. 10.1002/pst.339
- By:
- Publication type:
- Article
6
Understanding uncertainty Lindley D (2006) ISBN: 0470043830; 250 pages; £34.50, €48.90, $64.95 Wiley;.
- Published in:
- Pharmaceutical Statistics, 2008, v. 7, n. 4, p. 305, doi. 10.1002/pst.330
- By:
- Publication type:
- Article
7
Fitting models for the joint action of two drugs using SAS<sup>(R)</sup>.
- Published in:
- Pharmaceutical Statistics, 2008, v. 7, n. 4, p. 272, doi. 10.1002/pst.312
- By:
- Publication type:
- Article
8
ICH-E9 reflections and considerations.
- Published in:
- Pharmaceutical Statistics, 2008, v. 7, n. 4, p. 233, doi. 10.1002/pst.345
- By:
- Publication type:
- Article
9
Erratum: Combining p-values in large-scale genomics experiments. DOI: 10.1002/pst.304. Pharmaceut. Statist. 2007; 6: 217-226.
- Published in:
- Pharmaceutical Statistics, 2008, v. 7, n. 4, p. 308, doi. 10.1002/pst.356
- By:
- Publication type:
- Article
10
Conditional approval: discussion points from the PSI conditional approval expert group.
- Published in:
- Pharmaceutical Statistics, 2008, v. 7, n. 4, p. 263, doi. 10.1002/pst.309
- By:
- Publication type:
- Article
11
Lessons from TGN1412 and TARGET: implications for observational studies and meta-analysis.
- Published in:
- Pharmaceutical Statistics, 2008, v. 7, n. 4, p. 294, doi. 10.1002/pst.322
- By:
- Publication type:
- Article
12
Sample size estimation for non-inferiority trials of time-to-event data.
- Published in:
- Pharmaceutical Statistics, 2008, v. 7, n. 4, p. 236, doi. 10.1002/pst.292
- By:
- Publication type:
- Article
13
Conditional approval: discussion points from the PSI conditional approval expert group - rejoinder from the regulator.
- Published in:
- Pharmaceutical Statistics, 2008, v. 7, n. 4, p. 270, doi. 10.1002/pst.308
- By:
- Publication type:
- Article